null - FindTrial

N/A - LICORN

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2012-000232-25-FR

Enrollment

Unknown

Registered

2012-08-27

Start date

2012-06-27

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

MedDRA version: 19.1 Level: LLT Classification code 10068176 Term: Coronary artery bypass graft System Organ Class: 100000004865

Interventions

Trade Name: simdax Product Name: Simdax Pharmaceutical Form: Concentrate for solution for infusion INN or Proposed INN: levosimendan Concentration unit: mg/ml milligram(s)/millilitre Concentration ty

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Main Objective: ;Secondary Objective: ;Primary end point(s):	—

Countries

France

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Mar 12, 2026